Jason Andrade Presents Evidence Supporting Reduced Need for OAC Post-AF Ablation
Jason Andrade, Cardiologist at Vancouver Coastal Health, Elite Expert in Atrial Fibrillation, Co-chair of CCS, posted on X:
”In light of the recently published ALONE-AF trial, which tested the hypothesis that OAC discontinuation post ablation was a safe(r) strategy for patients I thought it would be good to review our recently larger meta-analysis on the topic.
In this analysis we examined 63 RCTs containing 11,161 patients
We found catheter ablation:
– Reduced the risk of stroke by 37% (7 less stroke per 1000 treated patients)
– Reduced the risk of death by 23% (16 less deaths per 1000 treated patients)
In conclusion, this large analysis of multiple RCTs shows that ablation reduces hard cardiovascular outcomes with high certainty.
Thus providing rationale for why OAC may not be necessary post ablation, as the risk of stroke is substantially reduced (eg 1.5% in OPTION, and 0.3-0.8% in ALONE-AF).”
Read the full study here.
Title: Catheter and Surgical Ablation for Atrial Fibrillation: A Systematic Review and Meta-analysis
Authors: Bryce Montané, Shiyang Zhang, Jonathan D. Wolfe, Sabrina Prime, Chongliang Luo, Daniel H. Cooper, Michelle Doering, Carina Blomstrom-Lundqvist, Samer A.M. Nashef, Pavel Osmancik, Jason G. Andrade, Emanuele Bertaglia, Ratika Parkash, Daniel B. Mark, Jens C. Nielsen, Linda D. Sharples, Brian F. Gage
Stay updated with Hemostasis Today.
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
-
Dec 18, 2025, 15:12Wolfgang Miesbach on Insights from Guy Young’s ASH2025 Session on Next-Generation Gene Therapy
-
Dec 18, 2025, 14:15Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
-
Dec 18, 2025, 13:55Laurent Bertoletti: BAT-VTE is One of 7 Projects Funded Under the EFFECT Trial Call!
-
Dec 18, 2025, 13:34Alexandru Stieber Explores VEXAS Syndrome